The SURPASS-2 trial directly compared tirzepatide to semaglutide 1.0 mg in patients with type 2 diabetes, providing the cleanest head-to-head data available
However, this timeframe assumes minimal humidity exposure, protection from light, and sealed packaging integrity
The powder is stored at -20 degrees C, protected from light and moisture
Oral tirzepatide is an innovative oral medication for weight loss that combines GLP-1 and GIP activity in a daily pill
Safety advice Do not use this medicine if you have type 1 diabetes, diabetic ketoacidosis, or a known allergy to semaglutide or any tablet ingredient
veterans, revealing how statin use, BMI, and cardiorespiratory fitness (CRF) interact to influence insulin initiation risk in patients with T2D